Get Started

EDIT

NASD Editas Medicine, Inc.
Nov 5, 2026 · 9:15 AM ET LAST TRADE Market Closed

$2.62 ↓ -0.10 (-3.68%) Trading Down from the previous close of $2.72

YTD change
+27.80%
vs 20-day SMA
+1.09%
vs 200-day SMA
-2.59%

Price ranges

Previous day
$2.61 $2.79
open $2.70 close $2.72
+$0.02 (+0.74%)
Today
$0.00 $0.00
$2.62
Past week
$2.55 $2.98
from $2.95 now $2.62
-$0.33 (-11.19%)
Past month
$2.25 $2.98
from $2.75 now $2.62
-$0.13 (-4.73%)
This year
$1.66 $3.94
from $2.05 now $2.62
+$0.57 (+27.80%)

Price & Performance

-0.32 (-10.53%) / 6M

$2.15$2.72$3.30$3.87May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 97.4% away from all-time highs of $99.95
  • EDIT is up 28% since the beginning of the year
  • EDIT is down 6% over the past 12 months
  • EDIT is down 5% over the past 1 month
  • 25% of all EDIT investors are betting against EDIT

EDIT reads not so good: price sits above one of the two key moving averages, the 12-month move is -2.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.15
Earnings momentum +20.5% Quarterly EPS growth
Quarterly change +20.5%

Valuation

P/E ratio N/A
Enterprise value $184.1M
Beta 2.93

Balance sheet & scale

IncomeN/A
Revenue$47.0M
Cash$211.6M
Debt$71.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $402.4M

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.